Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS Extension Study in Heart Transplant Recipients
NCT00238446Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mycophenolate sodium in heart transplant rejection, sponsored by Novartis. Started Apr 2003; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT00238446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238446.